414 filings
Page 6 of 21
DEFA14A
5ul9lesm6zj 1a
28 Apr 20
Additional proxy soliciting materials
4:54pm
UPLOAD
gy2i9au13ge3
27 Apr 20
Letter from SEC
12:00am
8-K
xyxeeitk0r6fn
22 Apr 20
Entry into a Material Definitive Agreement
8:05am
8-K
toq7dltirf e2yxz7huy
20 Apr 20
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
8:05am
8-K
3odo3iolq
30 Mar 20
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
6:10am
8-K
d350t4
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
dj5kh
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
y2o 9f8549v
9 Mar 20
Cocrystal Pharma Announces Plans to Advance Coronavirus Program
9:27am
8-K
c5j1gdn
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
u0p86dcvpx44zier
4 Mar 20
Regulation FD Disclosure
8:30am
424B5
f722d2dij0inxl2daps
28 Feb 20
Prospectus supplement for primary offering
1:27pm
8-K
1aggom12t3xvd586w
24 Feb 20
Entry into a Material Definitive Agreement
9:00am
8-K
y9e6s0f
18 Feb 20
Regulation FD Disclosure
8:30am
424B5
d6iwt6rxv wftfjm9
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
gkefau9bq hg9y
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
ba7k9r2rbr1c7
31 Jan 20
Prospectus supplement for primary offering
8:01am
8-K
syod jes1rwwq
29 Jan 20
Entry into a Material Definitive Agreement
9:40am